Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.
Clinical Indications for   PET.CT Imaging      in UrologyThomas F. Heston, MD, FACNM, FASNC, FAAFP
Why PET/CT Works:The Warburg Effect●    Normal Cells       ●           Low rate of glycolysis       ●           Aerobic me...
Imaging Glycolysis: 18-F FDG
Imaging the glycolisis: Positron Emission Tomography                                     511 γ                            ...
Imaging the Warburg Effect: Why it Works
The Warburg Effect: Cancer Types●    Nearly all solid tissue tumors       ●           Lung       ●           Colon       ●...
Urological Tumors: limited value●    Renal mass: C●    Renal cell carcinoma: C (M-staging)●    Testicular Cancer: C       ...
18-F FDG PET/CT Works Because:●    Tumor cells have increased glycolysis●    O-18 enriched water bombarded by protons     ...
Imaging the Warburg Effect: Normal vs Abnormal
Normal PET/CT
Abnormal PET/CT
Prostate Cancer
Prostate Cancer: FDG Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nuc...
C-11 choline vs F-18 FDG Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin...
Prostate Cancer:                                                   FDG vs MDP                                             ...
F-18 NaF vs Tc-99m MDP●    PET/CT more accurate       ●           Sensitivity: 90% vs 80%       ●           Specificity: 9...
PET/CT vs SPECT http://www.cms.gov/mcd/publiccomment_popup.asp?comment_id=19917
Dual Tracer Acquisition                                                                                          10:1 FDG/...
Dual Tracer Acquisition
Dual Tracer Fusion   Single CT aquisition, Single FDG acquisition, Single F-18 acquisitionBridges RL, Wiley CR, Christian ...
PET/CT in Prostate Cancer:Conclusions●    Workup: in selected patients only●    Restaging in pts with PSA relapse       ● ...
Renal Cell Carcinoma
Renal Cell                                                             Carcinoma:                                         ...
Prochain SlideShare
Chargement dans…5
×

Arab Health 2011: PET/CT Imaging in Urology

2 766 vues

Publié le

Clinical indications for PET/CT and Molecular imaging in patients with urologic conditions, primarily prostate and renal cancer.

Publié dans : Santé & Médecine
  • DOWNLOAD FULL BOOKS, INTO AVAILABLE Format, ......................................................................................................................... ......................................................................................................................... 1.DOWNLOAD FULL. PDF EBOOK here { https://tinyurl.com/y6a5rkg5 } ......................................................................................................................... 1.DOWNLOAD FULL. EPUB Ebook here { https://tinyurl.com/y6a5rkg5 } ......................................................................................................................... 1.DOWNLOAD FULL. doc Ebook here { https://tinyurl.com/y6a5rkg5 } ......................................................................................................................... 1.DOWNLOAD FULL. PDF EBOOK here { https://tinyurl.com/y6a5rkg5 } ......................................................................................................................... 1.DOWNLOAD FULL. EPUB Ebook here { https://tinyurl.com/y6a5rkg5 } ......................................................................................................................... 1.DOWNLOAD FULL. doc Ebook here { https://tinyurl.com/y6a5rkg5 } ......................................................................................................................... ......................................................................................................................... ......................................................................................................................... .............. Browse by Genre Available eBooks ......................................................................................................................... Art, Biography, Business, Chick Lit, Children's, Christian, Classics, Comics, Contemporary, Cookbooks, Crime, Ebooks, Fantasy, Fiction, Graphic Novels, Historical Fiction, History, Horror, Humor And Comedy, Manga, Memoir, Music, Mystery, Non Fiction, Paranormal, Philosophy, Poetry, Psychology, Religion, Romance, Science, Science Fiction, Self Help, Suspense, Spirituality, Sports, Thriller, Travel, Young Adult,
       Répondre 
    Voulez-vous vraiment ?  Oui  Non
    Votre message apparaîtra ici
  • This discusses the Dual Tracer Single Acquisition (DTSA) method of PET/CT imaging using a cocktail of NaF and FDG.
       Répondre 
    Voulez-vous vraiment ?  Oui  Non
    Votre message apparaîtra ici

Arab Health 2011: PET/CT Imaging in Urology

  1. 1. Clinical Indications for PET.CT Imaging in UrologyThomas F. Heston, MD, FACNM, FASNC, FAAFP
  2. 2. Why PET/CT Works:The Warburg Effect● Normal Cells ● Low rate of glycolysis ● Aerobic metabolism● Most Cancer Cells ● High rate of glycolysis ● Anaerobic metabolism
  3. 3. Imaging Glycolysis: 18-F FDG
  4. 4. Imaging the glycolisis: Positron Emission Tomography 511 γ e+ e- 511 γ
  5. 5. Imaging the Warburg Effect: Why it Works
  6. 6. The Warburg Effect: Cancer Types● Nearly all solid tissue tumors ● Lung ● Colon ● Breast● Notable Exceptions ● Slow growth: prostate cancer (use 18F-fluoride) ● Mucinous: BAC ● Early Disease: tumors < 0.5 cm
  7. 7. Urological Tumors: limited value● Renal mass: C● Renal cell carcinoma: C (M-staging)● Testicular Cancer: C ● Useful in stage II germ cell tumors ● Useful for identifying recurrence ● Most useful in seminomas● Bladder cancer: C● Prostate cancer: D
  8. 8. 18-F FDG PET/CT Works Because:● Tumor cells have increased glycolysis● O-18 enriched water bombarded by protons ---> F-18 ---> 18F-FDG● FDG hits a metabolic dead end● PET images 18F positron emissions● CT allows anatomic localization
  9. 9. Imaging the Warburg Effect: Normal vs Abnormal
  10. 10. Normal PET/CT
  11. 11. Abnormal PET/CT
  12. 12. Prostate Cancer
  13. 13. Prostate Cancer: FDG Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004 Oct;34(4):274-92. Review. PubMed PMID: 15493005
  14. 14. C-11 choline vs F-18 FDG Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004 Oct;34(4):274-92. Review. PubMed PMID: 15493005
  15. 15. Prostate Cancer: FDG vs MDP Initial: FDG positive, MDP positive (panel A and C-left) 6-months later post- therapy: FDG negative, MDP no/little change (panel B and C-right)Schöder H, Larson SM. Positron emission tomography for prostate, bladder, andrenal cancer. Semin Nucl Med. 2004 Oct;34(4):274-92. Review. PubMed PMID:15493005
  16. 16. F-18 NaF vs Tc-99m MDP● PET/CT more accurate ● Sensitivity: 90% vs 80% ● Specificity: 95%+ vs 90%● PET/CT more comfortable ● Shorter uptake time ● Shorter scan time
  17. 17. PET/CT vs SPECT http://www.cms.gov/mcd/publiccomment_popup.asp?comment_id=19917
  18. 18. Dual Tracer Acquisition 10:1 FDG/NaF Acquisition Soft + Bone + (breast CA)Bridges RL, Wiley CR, Christian JC, Strohm AP. An introduction to Na(18)F bone scintigraphy: basic principles,advanced imaging concepts, and case examples. J Nucl Med Technol. 2007 Jun;35(2):64-76
  19. 19. Dual Tracer Acquisition
  20. 20. Dual Tracer Fusion Single CT aquisition, Single FDG acquisition, Single F-18 acquisitionBridges RL, Wiley CR, Christian JC, Strohm AP. An introduction to Na(18)F bone scintigraphy: basic principles,advanced imaging concepts, and case examples. J Nucl Med Technol. 2007 Jun;35(2):64-76
  21. 21. PET/CT in Prostate Cancer:Conclusions● Workup: in selected patients only● Restaging in pts with PSA relapse ● Nodal disease ● Osseous disease ● Dual FDG / NaF imaging
  22. 22. Renal Cell Carcinoma
  23. 23. Renal Cell Carcinoma: Staging Tumor extension into the right renal vein and inferior vena cavaSchöder H, Larson SM. Positron emission tomography for prostate, bladder, andrenal cancer. Semin Nucl Med. 2004 Oct;34(4):274-92. Review. PubMed PMID: 15493005
  24. 24. PET/CT in Renal CellCarcinoma: Conclusions● FDG excreted by the urinary tract● Indications ● Staging high risk patients for metastatic disease ● When other imaging is non-diagnostic
  25. 25. Research Studies
  26. 26. PET/CT vs Bone Scan - 1● 44 pts with high risk prostate cancer ● Gleson score >= 8 or PSA >= 20 ng/mL● Prevalence: 52% with bony mets● Gold Standard ● All imaging results including MRI & CT ● Biopsy in selected cases ● Clinical follow-upEven-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastasesin patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006 Feb;47(2):287-97.
  27. 27. PET/CT vs Bone Scan - 2Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastasesin patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006 Feb;47(2):287-97.
  28. 28. PET/CT vs Bone Scan - 3 Bone Scan PET/CT ScanEven-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastasesin patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006 Feb;47(2):287-97.
  29. 29. FDG PET/CT vs MDP Bone Scan - 1● 70 pts with a variety of cancers with bone mets● Per Patient Basis: PET/CT 97% vs BS 86% sensitivity● Per Lesion Basis: PET/CT 92% vs BS 70% sensitivity● Incidental Findings: in 24 patients, organ metastases were found and in 7/7 pts with unknown primary, the primary was foundOzülker T, Küçüköz Uzun A, Ozülker F, Ozpaçac T. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDPbone scintigraphy for the detection of bone metastases in cancer patients. Nucl Med Commun. 2010Jun;31(6):597-603.
  30. 30. FDG PET/CT vs MDP Bone Scan - 2 MDP - Equivocal PET/CT - DefiniteOzülker T, Küçüköz Uzun A, Ozülker F, Ozpaçac T. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDPbone scintigraphy for the detection of bone metastases in cancer patients. Nucl Med Commun. 2010Jun;31(6):597-603.
  31. 31. Questions? Tawam Molecular Imaging Centre
  32. 32. Thank You!

×